Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Certara (CERT) EPS (Weighted Average and Diluted) (2020 - 2026)

Certara posted quarterly EPS (Weighted Average and Diluted) of -$0.06 for Q1 2026, down 300.0% year-on-year from $0.03 in Q1 2025, and down 50.0% on a QoQ basis from -$0.04 in Q4 2025.

Certara (CERT) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.06 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 300.0% year-over-year to -$0.06; the trailing twelve-month figure through Mar 2026 stood at -$0.1 (down 400.0% YoY), and the FY2025 full-year result was -$0.01, up 87.5% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.06, down from -$0.04 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.06 in Q4 2022 and bottomed at -$0.31 in Q3 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.0 (2022), against an average of -$0.02.
  • Peak annual rise in EPS (Weighted Average and Diluted) reached 897.01% in 2023, while the deepest fall reached 1650.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.06 in 2022, then sank by 233.33% to -$0.08 in 2023, then jumped by 150.0% to $0.04 in 2024, then sank by 200.0% to -$0.04 in 2025, then tumbled by 50.0% to -$0.06 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$0.06 (Q1 2026), -$0.04 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.48
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.67
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.82
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.41
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.10
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.22
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -0.10
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.02
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.25
10 Certara 966.25 Mn 816.76 Mn 93.56 Mn -0.06

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.06
Dec 31, 2025 -0.04
Sep 30, 2025 0.01
Jun 30, 2025 -0.01
Mar 31, 2025 0.03
Dec 31, 2024 0.04
Sep 30, 2024 -0.01
Jun 30, 2024 -0.08
Mar 31, 2024 -0.03
Dec 31, 2023 -0.08
Sep 30, 2023 -0.31
Jun 30, 2023 0.03
Mar 31, 2023 0.01
Dec 31, 2022 0.06
Sep 30, 2022 0.02
Jun 30, 2022 0.00
Mar 31, 2022 0.01
Dec 31, 2021 -0.07
Sep 30, 2021 -0.01
Jun 30, 2021 -0.02
Mar 31, 2021 0.01
Dec 31, 2020 -0.41
Sep 30, 2020 0.01
Jun 30, 2020 0.02
Mar 31, 2020 0.01